Literature DB >> 17605113

[Cushing's syndrome with bilateral nodular adrenal enlargement].

M op den Winkel1, C J Auernhammer, K W Jauch, G Assmann, C Dietz, K G Parhofer.   

Abstract

ACTH-independent macronodular bilateral adrenal hyperplasia (AIMAH) is a rare cause of endogenous Cushing's syndrome. Here, massive bilateral adrenal enlargement is accompanied by ACTH-independent hypercortisolism. The detection of ectopic hormone receptors which, according to a new concept, control the cortisol production in AIMAH, offers the opportunity of normalizing the hypercortisolism by pharmacologically influencing the receptor or its ligand. We here present the case of a 46 year old male patient. Using clinical and pharmacological tests we found evidence of ectopic receptors in the AIMAH. After suspicion was erroneously raised that a malignant lesion could be inside of the right adrenal mass, the decision was made to resect both adrenals instead of trying to treat the hypercortisolism by pharmacological means. This surgical approach (bilateral adrenalectomy) has been the standard way of treatment for AIMAH until the new concept of the ectopic receptors was developed.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17605113     DOI: 10.1007/s00108-007-1896-8

Source DB:  PubMed          Journal:  Internist (Berl)        ISSN: 0020-9554            Impact factor:   0.743


  9 in total

1.  A case of ACTH-independent macronodular adrenal hyperplasia: simultaneous expression of several aberrant hormone receptors in the adrenal gland.

Authors:  Nobuhiro Miyamura; Atsuyuki Tsutsumi; Hiroko Senokuchi; Kazuhiko Nakamaru; Junji Kawashima; Kohji Sakai; Tetsuya Taguchi; Hiroshi Tokunaga; Kenro Nishida; Masaya Uehara; Michiharu Sakakida; Eiichi Araki
Journal:  Endocr J       Date:  2003-06       Impact factor: 2.349

2.  Food-dependent Cushing's syndrome resulting from abundant expression of gastric inhibitory polypeptide receptors in adrenal adenoma cells.

Authors:  W W de Herder; L J Hofland; T B Usdin; F H de Jong; P Uitterlinden; P van Koetsveld; E Mezey; T I Bonner; H J Bonjer; S W Lamberts
Journal:  J Clin Endocrinol Metab       Date:  1996-09       Impact factor: 5.958

3.  Ectopic and abnormal hormone receptors in adrenal Cushing's syndrome.

Authors:  A Lacroix; N Ndiaye; J Tremblay; P Hamet
Journal:  Endocr Rev       Date:  2001-02       Impact factor: 19.871

4.  Adrenocorticotropin-independent bilateral macronodular adrenal hyperplasia: an unusual cause of Cushing's syndrome.

Authors:  C D Malchoff; J Rosa; C R DeBold; R A Kozol; G R Ramsby; D L Page; D M Malchoff; D N Orth
Journal:  J Clin Endocrinol Metab       Date:  1989-04       Impact factor: 5.958

5.  Are ectopic or abnormal membrane hormone receptors frequently present in adrenal Cushing's syndrome?

Authors:  H Mircescu; J Jilwan; N N'Diaye; I Bourdeau; J Tremblay; P Hamet; A Lacroix
Journal:  J Clin Endocrinol Metab       Date:  2000-10       Impact factor: 5.958

Review 6.  Bilateral adrenal Cushing's syndrome: macronodular adrenal hyperplasia and primary pigmented nodular adrenocortical disease.

Authors:  André Lacroix; Isabelle Bourdeau
Journal:  Endocrinol Metab Clin North Am       Date:  2005-06       Impact factor: 4.741

Review 7.  Cushing's syndrome variants secondary to aberrant hormone receptors.

Authors:  André Lacroix; Valérie Baldacchino; Isabelle Bourdeau; Pavel Hamet; Johanne Tremblay
Journal:  Trends Endocrinol Metab       Date:  2004-10       Impact factor: 12.015

8.  Cushing syndrome due to primary pigmented nodular adrenocortical disease: findings at CT and MR imaging.

Authors:  J L Doppman; W D Travis; L Nieman; D L Miller; G P Chrousos; M T Gomez; G B Cutler; D L Loriaux; J A Norton
Journal:  Radiology       Date:  1989-08       Impact factor: 11.105

Review 9.  CT and MR imaging of the adrenal glands in ACTH-independent cushing syndrome.

Authors:  Andrea G Rockall; Syed A Babar; S A Aslam Sohaib; Andrea M Isidori; Salvador Diaz-Cano; John P Monson; Ashley B Grossman; Rodney H Reznek
Journal:  Radiographics       Date:  2004 Mar-Apr       Impact factor: 5.333

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.